Net Cash Provided by (Used in) Operating Activities |
21.5M |
USD |
+10.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-271M |
USD |
-238% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
287M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
139M |
shares |
+0.46% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
36.9M |
USD |
-68.7% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
144M |
USD |
-56.3% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
117M |
USD |
+13.5% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
28M |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Gross |
21.7M |
USD |
+30.7% |
Q4 2023 |
FY 2023 |
Depreciation |
9.5M |
USD |
+11% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
17.8M |
USD |
+21.1% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
2.74B |
USD |
+0.53% |
Q3 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2022 |
Q1 2023 |
Interest Expense |
461M |
USD |
+5.71% |
Q3 2024 |
Q3 2024 |